China NMPA legacy archive 粤械注准20242401696B-type Natriuretic Peptide (BNP) Quality Control
- Device class
- Class II
- Model specifications
- Lyophilized powder type, level 1: 0.5mL×1; level 2: 0.5mL×1; level 3: 0.5mL×1.
- Approval department
- Guangdong Provincial Drug Administration
- Registration number
- 粤械注准20242401696
- Approval date
- December 19, 2024
- Expiry date
- December 18, 2029
- Province/Region
- Guangdong
- Address
- No. 8, Lizhishan Road, Science City, Huangpu District, Guangzhou
- Production address
- 广州市黄埔区科学城荔枝山路8号
本产品适用于监控和评价广州万孚生物技术股份有限公司生产的B 型钠尿肽(BNP)测定试剂(干式荧光免疫一步法)检测时的质量控制.
本产品适用于监控和评价广州万孚生物技术股份有限公司生产的B 型钠尿肽（BNP）测定试剂（干式荧光免疫一步法）检测时的质量控制。
This product is a lyophilized powder, the main component is B-type natriuretic peptide (BNP) antigen.
本产品为冻干粉，主要成分为B型钠尿肽（BNP）抗原。
4℃～30℃密封避光保存,有效期为12个月.开盖复溶后在4℃～30℃可保存8小时,分装后可在-20℃条件下冻存28天,仅可冻融一次,不可反复冻融.
4℃～30℃密封避光保存，有效期为12个月。开盖复溶后在4℃～30℃可保存8小时，分装后可在-20℃条件下冻存28天，仅可冻融一次，不可反复冻融。
- Appendix
- 产品技术要求、说明书
This static archive preserves historical registration fields and translations for B-type Natriuretic Peptide (BNP) Quality Control, registration 粤械注准20242401696. It does not establish current authorization or complete current product details.
The default China search uses the separately verified domestic-registration listing, checked daily. Its published listing fields and scope differ from this older snapshot.